Predictors and Prognostic Impact of Left Ventricular Ejection Fraction Recovery after Impella-Supported Percutaneous Coronary Interventions in Acute Myocardial Infarction

被引:4
作者
Marin, Federico [1 ]
Pighi, Michele [1 ]
Zucchelli, Federico [1 ]
Ruzzarin, Alessandro [1 ]
Russo, Giulio [2 ]
Aurigemma, Cristina [2 ]
Romagnoli, Enrico [2 ]
Ferrero, Valeria [1 ]
Piccoli, Anna [1 ]
Scarsini, Roberto [1 ]
Pesarini, Gabriele [1 ]
Trani, Carlo [2 ,3 ]
Burzotta, Francesco [2 ,3 ]
Ribichini, Flavio Luciano [1 ]
机构
[1] Univ Verona, Dept Med, Div Cardiol, I-37126 Verona, Italy
[2] Fdn Policlin Univ A Gemelli IRCCS, Dept Cardiovasc Med, I-00168 Rome, Italy
[3] Univ Cattolica Sacro Cuore, Dept Cardiovasc & Pulm Sci, I-00168 Rome, Italy
关键词
hemodynamic support; percutaneous coronary intervention; acute coronary syndrome; COMPLETE REVASCULARIZATION; RANDOMIZED-TRIAL; BALLOON PUMP; DISEASE; LESION;
D O I
10.3390/jpm12101576
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Aim: The aim of our study is to assess the predictors and the prognostic role of left ventricle ejection fraction (LVEF) recovery after Impella-supported percutaneous coronary intervention (PCI) in patients presenting with acute myocardial infarction (AMI). Methods: This retrospective, observational study included patients admitted for AMI who underwent Impella-supported PCI in two Italian high-volume cardiac catheterization laboratories. Only patients who underwent an echocardiographic assessment of left ventricle ejection fraction (LVEF) before the procedure (acute LVEF) and during follow-up (follow-up LVEF) were included in the present analysis. Patients with a baseline LVEF >= 40% were excluded from the present analysis. LVEF recovery was calculated as the difference between follow-up LVEF and acute LVEF. A delta >= 5% was considered significant and was used to define the responder group. Results: From April 2007 to December 2020, 64 consecutive patients were included in our study. A total of 55 patients (86%) received hemodynamic support with Impella 2.5, and 9 patients (14%) with Impella CP. Median LVEF at follow-up was significantly higher compared to baseline (36% (30-42) vs. 30% (24-33), p < 0.001). Based on LVEF recovery, 37 patients (57.8%) were deemed responders. According to multivariate analysis, complete functional revascularization was an independent predictor of a significant EF recovery (OR: 0.159; 95% CI: 0.038-0.668; p = 0.012). At three-year follow-up, lack of LVEF recovery was the only predictor of mortality (HR: 5.315; 95% CI: 1.100-25.676; p = 0.038). Conclusions: Functional complete revascularization is an independent predictor of the recovery of LVEF in patients presenting with AMI who underwent Impella-supported PCI. The recovery of LV function is associated with improved prognosis and could be used to stratify the risk of future events at long-term follow-up.
引用
收藏
页数:14
相关论文
共 22 条
[1]   Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography [J].
Bax, JJ ;
Poldermans, D ;
Elhendy, A ;
Cornel, JH ;
Boersma, E ;
Rambaldi, R ;
Roelandt, JRTC ;
Fioretti, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :163-169
[2]   Impact of chronic total occlusion and revascularization strategy in patients with infarct-related cardiogenic shock: A subanalysis of the culprit-shock trial [J].
Braik, Nassim ;
Guedeney, Paul ;
Behnes, Micheal ;
Desch, Steffen ;
Barthelemy, Olivier ;
Sandri, Marcus ;
De Waha-Thiele, Suzanne ;
Fuernau, Georg ;
Rouanet, Stephanie ;
Hauguel-Moreau, Marie ;
Zeitouni, Michel ;
Overtchouk, Pavel ;
Ouarrak, Taoufik ;
Schneider, Steffen ;
Zeymer, Uwe ;
Thiele, Holger ;
Montalescot, Gilles ;
Akin, Ibrahim .
AMERICAN HEART JOURNAL, 2021, 232 :185-193
[3]   Long-Term Outcomes of Extent of Revascularization in Complex High Risk and Indicated Patients Undergoing Impella-Protected Percutaneous Coronary Intervention: Report from the Roma-Verona Registry [J].
Burzotta, Francesco ;
Russo, Giulio ;
Ribichini, Flavio ;
Piccoli, Anna ;
D'Amario, Domenico ;
Paraggio, Lazzaro ;
Previ, Leonardo ;
Pesarini, Gabriele ;
Porto, Italo ;
Leone, Antonio Maria ;
Niccoli, Giampaolo ;
Aurigemma, Cristina ;
Verdirosi, Diana ;
Crea, Filippo ;
Trani, Carlo .
JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2019,
[4]   Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group [J].
Burzotta, Francesco ;
Trani, Carlo ;
Doshi, Sagar N. ;
Townend, Jonathan ;
van Geuns, Robert Jan ;
Hunziker, Patrick ;
Schieffer, Bernhard ;
Karatolios, Konstantinos ;
Moller, Jacob Eifer ;
Ribichini, Flavio L. ;
Schaefer, Andreas ;
Henriques, Jose P. S. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 201 :684-691
[5]   High-risk percutaneous coronary intervention: how to define it today? [J].
De Marzo, Vincenzo ;
D'Amario, Domenico ;
Galli, Mattia ;
Vergallo, Rocco ;
Porto, Italo .
MINERVA CARDIOANGIOLOGICA, 2018, 66 (05) :576-593
[6]   Prognostic Utility of BCIS Myocardial Jeopardy Score for Classification of Coronary Disease Burden and Completeness of Revascularization [J].
De Silva, Kalpa ;
Morton, Geraint ;
Sicard, Pierre ;
Chong, Eric ;
Indermuehle, Andreas ;
Clapp, Brian ;
Thomas, Martyn ;
Redwood, Simon ;
Perera, Divaka .
AMERICAN JOURNAL OF CARDIOLOGY, 2013, 111 (02) :172-177
[7]   A Prospective Feasibility Trial Investigating the Use of the Impel la 2.5 System in Patients Undergoing High-Risk Percutaneous Coronary Intervention (The PROTECT I Trial) Initial US Experience [J].
Dixon, Simon R. ;
Henriques, Jose P. S. ;
Mauri, Laura ;
Sjauw, Krischan ;
Civitello, Andrew ;
Kar, Biswajit ;
Loyalka, Pranav ;
Resnic, Frederic S. ;
Teirstein, Paul ;
Makkar, Raj ;
Palacios, Igor F. ;
Collins, Michael ;
Moses, Jeffrey ;
Benali, Karim ;
O'Neill, William W. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (02) :91-96
[8]   Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial [J].
Engstrom, Thomas ;
Kelbaek, Henning ;
Helqvist, Steffen ;
Hofsten, Dan Eik ;
Klovgaard, Lene ;
Holmvang, Lene ;
Jorgensen, Erik ;
Pedersen, Frants ;
Saunamaki, Kari ;
Clemmensen, Peter ;
De Backer, Ole ;
Ravkilde, Jan ;
Tilsted, Hans-Henrik ;
Villadsen, Anton Boel ;
Aaroe, Jens ;
Jensen, Svend Eggert ;
Raungaard, Bent ;
Kober, Lars .
LANCET, 2015, 386 (9994) :665-671
[9]   Randomized Trial of Complete Versus Lesion-Only Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI and Multivessel Disease [J].
Gershlick, Anthony H. ;
Khan, Jamal Nasir ;
Kelly, Damian J. ;
Greenwood, John P. ;
Sasikaran, Thiagarajah ;
Curzen, Nick ;
Blackman, Daniel J. ;
Dalby, Miles ;
Fairbrother, Kathryn L. ;
Banya, Winston ;
Wang, Duolao ;
Flather, Marcus ;
Hetherington, Simon L. ;
Kelion, Andrew D. ;
Talwar, Suneel ;
Gunning, Mark ;
Hall, Roger ;
Swanton, Howard ;
McCann, Gerry P. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) :963-972
[10]   Real-world use of the Impella 2.5 circulatory support system in complex high-risk percutaneous coronary intervention: The USpella Registry [J].
Maini, Brijeshwar ;
Naidu, Srihari S. ;
Mulukutla, Suresh ;
Kleiman, Neal ;
Schreiber, Theodore ;
Wohns, David ;
Dixon, Simon ;
Rihal, Charanjit ;
Dave, Rajesh ;
O'Neill, William .
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 80 (05) :717-725